SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami in talks to buy Paras Pharma; deal may cost Rs. 4,000 cr

09 Sep 2010 Evaluate

Emami Ltd is in negotiations to acquire a controlling stake in unlisted Paras Pharmaceuticals Ltd for consideration of Rs 4,000 crore. Paras have over-the-counter (OTC) and personal care product brands such as Moov, Krack, Set Wet, D’Cold and RingGuard in its fold.

Two private equity firms, Actis Advisors Pvt. Ltd and Sequoia Capital India Advisors Pvt. Ltd, which jointly hold around 70% in Paras, have been looking to sell their stake in the company for around $700 million (Rs.3,269 crore), The remaining 30% stake in the firm is held by chairman and original promoter Girish Patel.

Emami had Rs.604 crore of cash reserves on its balance sheet as on 31 March and had passed an enabling resolution to raise Rs.1000 crore in June.

crackcrack

Emami Share Price

451.45 25.50 (5.99%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×